Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations

被引:283
作者
Moulton, MJ [1 ]
Creswell, LL [1 ]
Mackey, ME [1 ]
Cox, JL [1 ]
Rosenbloom, M [1 ]
机构
[1] WASHINGTON UNIV, DEPT SURG, DIV CARDIOTHORAC SURG, ST LOUIS, MO 63110 USA
关键词
D O I
10.1016/S0022-5223(96)70380-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Although previous studies have included early reexploration for bleeding as a risk factor in analyzing adverse outcomes after cardiac operations, reexploration for bleeding has not been systematically examined as a multivariate risk factor for increased morbidity and mortality after cardiac surgery. Furthermore, multivariate predictors of the need for reexploration have not been identified. Accordingly, we performed a retrospective analysis of 6100 patients requiring cardiopulmonary bypass from January 1, 1986, to December 31, 1993. Methods: Eighty-five patients who had ventricular assist devices were excluded from further analysis because of the prevalence of bleeding and the significant morbidity and mortality associated with placement of a ventricular assist device, unrelated to reexploration. In the remaining 6015 patients, potential adverse outcomes analyzed included operative mortality, mediastinitis, stroke, renal failure, adult respiratory distress syndrome, prolonged mechanical ventilation, sepsis, atrial arrhythmias, and ventricular arrhythmias. To control for the confounding effects of other risk factors, we performed a multivariate logistic regression analysis. Potential covariates considered in the logistic model included age, sex, race, history of reoperation, urgency of the operation, congestive heart failure, prior myocardial infarction, renal failure, diabetes, hypertension, chronic obstructive pulmonary disease or stroke, and the bypass and crossclamp time. Results: The overall incidence of reexploration was 4.2% (253/6015). Four independent risk factors-increased patient age (p < 0.001), preoperative renal insufficiency (p = 0.02), operation other than coronary bypass (p < 0.001), and prolonged bypass time (p = 0.03)-were identified as predictors of the need for reexploration. The preoperative use of aspirin, heparin, or thrombolytic agents and the bleeding time were not identified as predictors. Reexploration for bleeding was identified as a strong independent risk factor for operative mortality (p = 0.005), renal failure (p < 0.0001), prolonged mechanical ventilation (p < 0.0001), adult respiratory distress syndrome (p = 0.03), sepsis (p < 0.0001), and atrial arrhythmias (p = 0.006). Conclusion: These data indicate that meticulous attention to surgical hemostasis and possibly application of recently developed modalities designed to facilitate perioperative correction of coagulopathy could improve outcomes after cardiac operations.
引用
收藏
页码:1037 / 1044
页数:8
相关论文
共 16 条
  • [1] HAZARDS OF POSTOPERATIVE ATRIAL ARRHYTHMIAS
    CRESWELL, LL
    SCHUESSLER, RB
    ROSENBLOOM, M
    COX, JL
    [J]. ANNALS OF THORACIC SURGERY, 1993, 56 (03) : 539 - 549
  • [2] THE IMPACT OF HEPARIN CONCENTRATION AND ACTIVATED CLOTTING TIME MONITORING ON BLOOD CONSERVATION - A PROSPECTIVE, RANDOMIZED EVALUATION IN PATIENTS UNDERGOING CARDIAC OPERATION
    DESPOTIS, GJ
    JOIST, JH
    HOGUE, CW
    ALSOUFIEV, A
    KATER, K
    GOODNOUGH, LT
    SANTORO, SA
    SPITZNAGEL, E
    ROSENBLUM, M
    LAPPAS, DG
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) : 46 - 54
  • [3] PREOPERATIVE ASPIRIN INGESTION INCREASES OPERATIVE BLOOD-LOSS AFTER CORONARY-ARTERY BYPASS-GRAFTING
    FERRARIS, VA
    FERRARIS, SP
    LOUGH, FC
    BERRY, WR
    [J]. ANNALS OF THORACIC SURGERY, 1988, 45 (01) : 71 - 74
  • [4] Hosmer D., 1989, APPL LOGISTIC REGRES
  • [5] SELECTIVE APPROACH TO STERNAL CLOSURE AFTER EXPLORATION FOR HEMORRHAGE FOLLOWING CORONARY-ARTERY BYPASS
    JOHNSON, JA
    GUNDERSEN, AE
    STICKNEY, ID
    COGBILL, TH
    [J]. ANNALS OF THORACIC SURGERY, 1990, 49 (05) : 771 - 774
  • [6] KIRKLIN JW, 1993, CARDIAC SURG, P222
  • [7] THE IMPACT OF APROTININ ON CORONARY-ARTERY BYPASS GRAFT PATENCY
    LAUB, GW
    RIEBMAN, JB
    CHEN, C
    ADKINS, MS
    ANDERSON, WA
    FERNANDEZ, J
    MCGRATH, LB
    [J]. CHEST, 1994, 106 (05) : 1370 - 1375
  • [8] APROTININ FOR CORONARY-BYPASS OPERATIONS - EFFICACY, SAFETY, AND INFLUENCE ON EARLY SAPHENOUS-VEIN GRAFT PATENCY - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    LEMMER, JH
    STANFORD, W
    BONNEY, SL
    BREEN, JF
    CHOMKA, EV
    ELDREDGE, WJ
    HOLT, WW
    KARP, RB
    LAUB, GW
    LIPTON, MJ
    SCHAFF, HV
    TATOOLES, CJ
    RUMBERGER, JA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 543 - 553
  • [9] APROTININ FOR CORONARY-ARTERY BYPASS-GRAFTING - EFFECT ON POSTOPERATIVE RENAL-FUNCTION
    LEMMER, JH
    STANFORD, W
    BONNEY, SL
    CHOMKA, EV
    KARP, RB
    LAUB, GW
    RUMBERGER, JA
    SCHAFF, HV
    [J]. ANNALS OF THORACIC SURGERY, 1995, 59 (01) : 132 - 136
  • [10] DEAMINO-8-D-ARGININE VASOPRESSIN SHORTENS THE BLEEDING-TIME IN UREMIA
    MANNUCCI, PM
    REMUZZI, G
    PUSINERI, F
    LOMBARDI, R
    VALSECCHI, C
    MECCA, G
    ZIMMERMAN, TS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (01) : 8 - 12